|
SMAD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.955800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.723600E-01 |
| Normal-vs-Stage2 |
5.629200E-01 |
| Normal-vs-Stage3 |
5.884800E-03 |
| Normal-vs-Stage4 |
1.552090E-04 |
| Stage1-vs-Stage2 |
8.771400E-01 |
| Stage1-vs-Stage3 |
2.066100E-02 |
| Stage1-vs-Stage4 |
3.416600E-04 |
| Stage2-vs-Stage3 |
3.313000E-01 |
| Stage2-vs-Stage4 |
1.325990E-01 |
| Stage3-vs-Stage4 |
3.258400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.149800E-02 |
| Normal-vs-AfricanAmerican |
1.353800E-04 |
| Normal-vs-Asian |
9.176800E-01 |
| Caucasian-vs-AfricanAmerican |
3.379900E-03 |
| Caucasian-vs-Asian |
5.600800E-01 |
| AfricanAmerican-vs-Asian |
5.424500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.431800E-02 |
| Normal-vs-Female |
1.159560E-01 |
| Male-vs-Female |
5.087600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.447770E-02 |
| Normal-vs-Age(41-60Yrs) |
2.205800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.153800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.465000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.750100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.092800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.260000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.952990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.511000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.266800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.081400E-01 |
| Normal-vs-Grade 2 |
8.507200E-01 |
| Normal-vs-Grade 3 |
6.381000E-03 |
| Normal-vs-Grade 4 |
1.0469000000235E-06 |
| Grade 1-vs-Grade 2 |
7.533200E-01 |
| Grade 1-vs-Grade 3 |
8.934000E-02 |
| Grade 1-vs-Grade 4 |
2.103900E-03 |
| Grade 2-vs-Grade 3 |
5.382000E-03 |
| Grade 2-vs-Grade 4 |
7.97350000025787E-07 |
| Grade 3-vs-Grade 4 |
5.861200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.091800E-01 |
| Normal-vs-ccB subtype |
1.703750E-03 |
| ccA subtype-vs-ccB subtype |
2.2522999999941E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.650300E-02 |
| Normal-vs-N1 |
3.375600E-02 |
| N0-vs-N1 |
3.562800E-01 |
|
|
